Meningococcal vaccine groups A C Y W-135 conjugate (second generation) (Sanofi)

N/A

Report date: 2025/10/17 20:01:39

Base Information

Drug NameMeningococcal vaccine groups A C Y W-135 conjugate (second generation) (Sanofi)
Drug Alias NameMeninge ACTW conj - SanofiTetraMen-TMen Quad TTMenACYW conjugate vaccineMenQuadfi +[6] 
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisMeningococcal InfectionsMeningitis, Meningococcal
Global Approved IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/04/23
Country/TerritoryCzechiaUnited StatesVietnam +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiSanofi PasteurSanofi Kk
Inactive CompaniesN/A
Active IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Inactive IndicationsMeningitis

Other Information

ATC CodeJ07AH08
Related LinksN/A